{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06011824",
            "orgStudyIdInfo": {
                "id": "23-004958"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "A Study of Effect of Megakaryocytes and Platelets in Breast Cancer",
            "officialTitle": "Megakaryocytes and Platelets, Harmful or Helpful in Breast Cancer Cell Metastasis",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-of-effect-of-megakaryocytes-and-platelets-in-breast-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-08-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-09-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-08-08",
            "studyFirstSubmitQcDate": "2023-08-21",
            "studyFirstPostDateStruct": {
                "date": "2023-08-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-02",
            "lastUpdatePostDateStruct": {
                "date": "2023-10-04",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Determining if Megakaryocytes and Platelets are Harmful or Helpful in Breast Cancer Cell Metastasis",
            "detailedDescription": "The purpose of this study is to determine how megakaryocytes (cells in the bone marrow responsible for making platelets, which are necessary for blood clotting) affect the survival and growth/division patterns of breast cancer stem cells, and the effects of breast cancer cells on megakaryocyte survival and function. Through chart review, the study team will look at the relationship between different blood components and different breast cancer diagnoses."
        },
        "conditionsModule": {
            "conditions": [
                "Breast Cancer"
            ],
            "keywords": [
                "Megakaryocytes",
                "Platelets"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "Blood draw. 10-12 mL total into lavender-top (EDTA) tubes, however up to 24 mL may be obtained should a redraw be needed."
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Biopsy Negative",
                    "description": "Female age 18 and above with negative breast biopsy",
                    "interventionNames": [
                        "Other: Blood draw"
                    ]
                },
                {
                    "label": "Biopsy positive for carcinoma in situ (ductal, lobular, or other)",
                    "description": "Females age 18 and above with any subtype of breast cancer (ductal, lobular, or other)",
                    "interventionNames": [
                        "Other: Blood draw"
                    ]
                },
                {
                    "label": "Biopsy positive for Stage 1, 2, or 3 invasive carcinoma (ductal, lobular, or other)",
                    "description": "Females age 18 and above with any subtype of breast cancer (HER2+, ER/PR, TNBC, BRCA1 +/-, other).",
                    "interventionNames": [
                        "Other: Blood draw"
                    ]
                },
                {
                    "label": "Metastatic Stage IV",
                    "description": "Females age 18 and above with any subtype of breast cancer, including metastases",
                    "interventionNames": [
                        "Other: Blood draw"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Blood draw",
                    "description": "10-12mL of blood will be drawn one time, unless a redraw is needed, in which case up to 24 mL will be drawn (10-12 mL each draw)",
                    "armGroupLabels": [
                        "Biopsy Negative",
                        "Biopsy positive for Stage 1, 2, or 3 invasive carcinoma (ductal, lobular, or other)",
                        "Biopsy positive for carcinoma in situ (ductal, lobular, or other)",
                        "Metastatic Stage IV"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Platelet Counts",
                    "description": "Measure of the number of platelets in the blood, reported as platelets per microliter of blood.",
                    "timeFrame": "Baseline"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Mean Corpuscular Volume (MCV)",
                    "description": "Measures the average size of red blood cells, reported as femtoliters (fl).",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Lymphocyte to neutrophil ratio",
                    "description": "Ratio between the neutrophil and lymphocyte counts measured in peripheral blood.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Levels of tumor educated platelets",
                    "description": "Number of tumor educated platelets, measured by the analysis of cell surface markers for expression of certain markers such as VEGF, PDGFR, MMP1, TGFb, and or other cell adhesion molecules.",
                    "timeFrame": "Baseline"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nCohort 1-Biopsy negative\n\n-Females age 18 and above\n\nCohort 2-Biopsy positive for carcinoma in situ (ductal, lobular, or other)\n\n* Females age 18 and above\n* Any subtype of breast cancer\n\nCohort 3-Biopsy positive for Stage 1, 2, or 3 invasive carcinoma (ductal, lobular, or other)\n\n* Females age 18 and above\n* Any subtype of breast cancer\n* Have no distant metastases\n\nCohort 4-Stage 4 Metastatic Disease\n\n* Females age 18 and above\n* Any subtype of breast cancer\n\nExclusion Criteria:\n\nCohort 1-Biopsy negative\n\n* Males\n* Females less than age 18\n\nCohort 2-Biopsy positive for carcinoma in situ (ductal, lobular, or other)\n\n* Males\n* Females less than age 18\n* Currently undergoing neoadjuvant therapy\n\nCohort 3-Biopsy positive for Stage 1, 2, or 3 invasive carcinoma (ductal, lobular, or other)\n\n* Males\n* Females less than age 18\n* Presence of distant metastases\n* Currently undergoing neoadjuvant therapy\n\nCohort 4-Stage 4 Metastatic Disease\n\n* Males\n* Females less than age 18\n* Currently undergoing neoadjuvant therapy",
            "sex": "FEMALE",
            "genderBased": true,
            "genderDescription": "Biological females",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "For the prospective study: 20 women after biopsy for suspicious mammogram findings, 10 women with newly diagnosed metastatic cancer.\n\nSubject population (children, adults, groups): Women undergoing biopsy or suspicious mammogram finds and newly diagnosed female metastatic breast cancer patients.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trials Referral Office",
                    "role": "CONTACT",
                    "phone": "855-776-0015",
                    "email": "mayocliniccancerstudies@mayo.edu"
                },
                {
                    "name": "Leandra Pake",
                    "role": "CONTACT",
                    "phone": "608-392-9719",
                    "email": "Franzen.Leandra@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Scott H. Okuno, M.D.",
                    "affiliation": "Mayo Clinic Health System-Franciscan Healthcare",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic Health System-Franciscan Healthcare",
                    "status": "RECRUITING",
                    "city": "La Crosse",
                    "state": "Wisconsin",
                    "zip": "54601",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Trials",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Leandra Pake",
                            "role": "CONTACT",
                            "phone": "608-392-9719",
                            "email": "Franzen.Leandra@mayo.edu"
                        },
                        {
                            "name": "Scott H. Okuno, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.80136,
                        "lon": -91.23958
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "relevance": "LOW"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}